fluoromisonidazole: Clinical Trials

6 trials of fluoromisonidazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 completed, 1 suspended. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Terminated 3, Completed 2, Suspended 1
Phase 21Completed 1

Follow fluoromisonidazole: new trials by email Literature Review of fluoromisonidazole trials Research Report on fluoromisonidazole

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma
18F-FMISO PET, 18F-FLT PET - Glioma
Phase 1SuspendedWeill Medical College of Cornell University82021-02-012026-01-27
FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas
18F-FMISO - Soft Tissue Sarcoma
Phase 1TerminatedUniversity of Pennsylvania52019-02-012021-03-18
Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
[18F]fluoromisonidazole, Bevacizumab, positron emission tomography (PET/CT). - Recurrent Glioblastoma
Phase 1TerminatedAbramson Cancer Center at Penn Medicine22018-04-182020-02-17
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
[18F]fluoro-2-deoxy-D-glucose (FDG), 1H-1-(3-[18F]-fluoro-2-hydroxy-propyl)-2-nitro-imidazole [18F]-fluoromisonidazole, [15O]water - Brain Cancer
Phase 1TerminatedUniversity of Utah22013-03-272024-10-01
Clinical Evaluation of the New Hypoxia Imaging Agent HX4
[F-18] FMISO, [F-18] HX4 - Head and Neck Cancer, Lung Cancer
Phase 1 / Phase 2CompletedSiemens Molecular Imaging122009-06-012012-09-25
PR104 and G-CSF in Treating Patients With Solid Tumors
filgrastim, PR104, F-18-fluoromisonidazole - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedProacta, Incorporated52008-02-012011-06-01

Conditions studied

Glioblastoma (2)  ·  Glioma (2)  ·  Brain Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Hypoxia (1)  ·  Liver Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Meningioma (1)  ·  Neoplasms (1)  ·  Sarcoma (1)

Sponsors

Abramson Cancer Center at Penn Medicine (1)  ·  Proacta, Incorporated (1)  ·  Siemens Molecular Imaging (1)  ·  University of Pennsylvania (1)  ·  University of Utah (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (5)  ·  China (1)  ·  New Zealand (1)

Top investigators

Jeffrey Yap, PhD (1)  ·  Sadek Nehmeh, PhD (1)  ·  Seyed Ali Nabavizadeh, MD (1)  ·  Yi Hui Guan, MD (1)